newsfilter
← Latest News
Business Wire·

Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK

Versavo® (bevacizumab) is indicated for the treatment of several types of cancers including metastatic colorectal cancer, advanced non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal